903 related articles for article (PubMed ID: 21388641)
1. Downregulation of the CXC chemokine receptor 4/stromal cell-derived factor 1 pathway enhances myocardial neovascularization, cardiomyocyte survival, and functional recovery after myocardial infarction.
Bonaros N; Sondermeijer H; Wiedemann D; Schlechta B; Schachner T; Schuster M; Seki T; Martens TP; Itescu S; Kocher AA
J Thorac Cardiovasc Surg; 2011 Sep; 142(3):687-96, 696.e1-2. PubMed ID: 21388641
[TBL] [Abstract][Full Text] [Related]
2. CCR3- and CXCR4-mediated interactions regulate migration of CD34+ human bone marrow progenitors to ischemic myocardium and subsequent tissue repair.
Bonaros N; Sondermeijer H; Schuster M; Rauf R; Wang SF; Seki T; Skerrett D; Itescu S; Kocher AA
J Thorac Cardiovasc Surg; 2008 Oct; 136(4):1044-53. PubMed ID: 18954648
[TBL] [Abstract][Full Text] [Related]
3. Stromal cell-derived factor and granulocyte-monocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy.
Woo YJ; Grand TJ; Berry MF; Atluri P; Moise MA; Hsu VM; Cohen J; Fisher O; Burdick J; Taylor M; Zentko S; Liao G; Smith M; Kolakowski S; Jayasankar V; Gardner TJ; Sweeney HL
J Thorac Cardiovasc Surg; 2005 Aug; 130(2):321-9. PubMed ID: 16077394
[TBL] [Abstract][Full Text] [Related]
4. Granulocyte colony-stimulating factor and stem cell factor improve endogenous repair after myocardial infarction.
Kanellakis P; Slater NJ; Du XJ; Bobik A; Curtis DJ
Cardiovasc Res; 2006 Apr; 70(1):117-25. PubMed ID: 16497284
[TBL] [Abstract][Full Text] [Related]
5. SDF-1α as a therapeutic stem cell homing factor in myocardial infarction.
Ghadge SK; Mühlstedt S; Ozcelik C; Bader M
Pharmacol Ther; 2011 Jan; 129(1):97-108. PubMed ID: 20965212
[TBL] [Abstract][Full Text] [Related]
6. Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts.
Wright LM; Maloney W; Yu X; Kindle L; Collin-Osdoby P; Osdoby P
Bone; 2005 May; 36(5):840-53. PubMed ID: 15794931
[TBL] [Abstract][Full Text] [Related]
7. Myocardial CXCR4 expression is required for mesenchymal stem cell mediated repair following acute myocardial infarction.
Dong F; Harvey J; Finan A; Weber K; Agarwal U; Penn MS
Circulation; 2012 Jul; 126(3):314-24. PubMed ID: 22685115
[TBL] [Abstract][Full Text] [Related]
8. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function.
Kocher AA; Schuster MD; Szabolcs MJ; Takuma S; Burkhoff D; Wang J; Homma S; Edwards NM; Itescu S
Nat Med; 2001 Apr; 7(4):430-6. PubMed ID: 11283669
[TBL] [Abstract][Full Text] [Related]
9. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease.
Heeschen C; Lehmann R; Honold J; Assmus B; Aicher A; Walter DH; Martin H; Zeiher AM; Dimmeler S
Circulation; 2004 Apr; 109(13):1615-22. PubMed ID: 15037527
[TBL] [Abstract][Full Text] [Related]
10. The CXCR4 agonist peptide, CTCE-0021, rapidly mobilizes polymorphonuclear neutrophils and hematopoietic progenitor cells into peripheral blood and synergizes with granulocyte colony-stimulating factor.
Pelus LM; Bian H; Fukuda S; Wong D; Merzouk A; Salari H
Exp Hematol; 2005 Mar; 33(3):295-307. PubMed ID: 15730853
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin administration after myocardial infarction in mice attenuates ischemic cardiomyopathy associated with enhanced homing of bone marrow-derived progenitor cells via the CXCR-4/SDF-1 axis.
Brunner S; Winogradow J; Huber BC; Zaruba MM; Fischer R; David R; Assmann G; Herbach N; Wanke R; Mueller-Hoecker J; Franz WM
FASEB J; 2009 Feb; 23(2):351-61. PubMed ID: 18827024
[TBL] [Abstract][Full Text] [Related]
12. Neovascularization and cardiomyocytes regeneration in acute myocardial infarction after bone marrow stromal cell transplantation: comparison of infarct-relative and noninfarct-relative arterial approaches in swine.
Yang ZJ; Ma DC; Wang W; Xu SL; Zhang YQ; Chen B; Zhou F; Zhu TB; Wang LS; Jia EZ; Zhang FM; Cao KJ; Xu ZQ; Ma WZ
Clin Chim Acta; 2007 Jun; 381(2):114-8. PubMed ID: 17400203
[TBL] [Abstract][Full Text] [Related]
13. Neovasculogenic therapy to augment perfusion and preserve viability in ischemic cardiomyopathy.
Atluri P; Liao GP; Panlilio CM; Hsu VM; Leskowitz MJ; Morine KJ; Cohen JE; Berry MF; Suarez EE; Murphy DA; Lee WM; Gardner TJ; Sweeney HL; Woo YJ
Ann Thorac Surg; 2006 May; 81(5):1728-36. PubMed ID: 16631663
[TBL] [Abstract][Full Text] [Related]
14. Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial.
Ripa RS; Jørgensen E; Wang Y; Thune JJ; Nilsson JC; Søndergaard L; Johnsen HE; Køber L; Grande P; Kastrup J
Circulation; 2006 Apr; 113(16):1983-92. PubMed ID: 16531621
[TBL] [Abstract][Full Text] [Related]
15. Pathways implicated in stem cell migration: the SDF-1/CXCR4 axis.
Vagima Y; Lapid K; Kollet O; Goichberg P; Alon R; Lapidot T
Methods Mol Biol; 2011; 750():277-89. PubMed ID: 21618098
[TBL] [Abstract][Full Text] [Related]
16. Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease.
Walter DH; Haendeler J; Reinhold J; Rochwalsky U; Seeger F; Honold J; Hoffmann J; Urbich C; Lehmann R; Arenzana-Seisdesdos F; Aicher A; Heeschen C; Fichtlscherer S; Zeiher AM; Dimmeler S
Circ Res; 2005 Nov; 97(11):1142-51. PubMed ID: 16254213
[TBL] [Abstract][Full Text] [Related]
17. GRK6 deficiency is associated with enhanced CXCR4-mediated neutrophil chemotaxis in vitro and impaired responsiveness to G-CSF in vivo.
Vroon A; Heijnen CJ; Raatgever R; Touw IP; Ploemacher RE; Premont RT; Kavelaars A
J Leukoc Biol; 2004 Apr; 75(4):698-704. PubMed ID: 14704365
[TBL] [Abstract][Full Text] [Related]
18. Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial.
Engelmann MG; Theiss HD; Hennig-Theiss C; Huber A; Wintersperger BJ; Werle-Ruedinger AE; Schoenberg SO; Steinbeck G; Franz WM
J Am Coll Cardiol; 2006 Oct; 48(8):1712-21. PubMed ID: 17045910
[TBL] [Abstract][Full Text] [Related]
19. The bispecific SDF1-GPVI fusion protein preserves myocardial function after transient ischemia in mice.
Ziegler M; Elvers M; Baumer Y; Leder C; Ochmann C; Schönberger T; Jürgens T; Geisler T; Schlosshauer B; Lunov O; Engelhardt S; Simmet T; Gawaz M
Circulation; 2012 Feb; 125(5):685-96. PubMed ID: 22223428
[TBL] [Abstract][Full Text] [Related]
20. Expression of functional CXCR4 by muscle satellite cells and secretion of SDF-1 by muscle-derived fibroblasts is associated with the presence of both muscle progenitors in bone marrow and hematopoietic stem/progenitor cells in muscles.
Ratajczak MZ; Majka M; Kucia M; Drukala J; Pietrzkowski Z; Peiper S; Janowska-Wieczorek A
Stem Cells; 2003; 21(3):363-71. PubMed ID: 12743331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
